Social Determinants of Health, Hospital-level Resources, and Risk of Septic Shock in Pediatric Leukemia |
Children’s Hospital of Philadelphia / Jenny Ruiz, MD |
Young Investigator Grants |
2021 |
Pennsylvania |
Targeting Metabolism as a Therapeutic Approach for High-Risk MYCN-Driven Neuroblastoma |
University of Pennsylvania / Nicole Anderson, PhD |
Young Investigator Grants |
2016 |
Pennsylvania |
The Role of DNA Methylation in Pediatric Cancer |
Fred Hutchinson Cancer Research Center / Scott Diede |
Young Investigator Grants |
2010 |
Washington |
Investigating the Role of the RNA Binding Protein LIN28 in Neuroblastoma |
Boston Children’s Hospital / John Powers |
Young Investigator Grants |
2012 |
Massachusetts |
A Translational Approach to Identify Drugs with Specific Activity Against EZH2 Mutant High Risk T-ALLs and ETP ALLs that Overexpress the JDP2 bZIP Transcription Factor |
Dana-Farber Cancer Institute / Shuning He, PhD |
Young Investigator Grants |
2015 |
Massachusetts |
Genetic Profiling and Experimental Modeling of High-risk Acute Lymphoblastic Leukemia |
St. Jude Children’s Research Hospital / Kathryn Roberts, PhD |
Young Investigator Grants |
2013 |
Tennessee |
Novel Synergistic Targets for Combination Therapy in Philadelphia Chromosome-like Acute Lymphoblastic Leukemia |
Children’s Hospital of Philadelphia / Yang Ding, MD |
Young Investigator Grants |
2020 |
Pennsylvania |
Aberrant DNA methylation in Ewing sarcoma.
|
Fred Hutchinson Cancer Research Center / Scott Borinstein |
Young Investigator Grants |
2009 |
Washington |
Divergent Core Transcriptional Regulatory Circuitries to Highlight Context-Specific Vulnerabilities in AML |
Dana-Farber Cancer Institute / Maxim Pimkin, MD/PhD |
Young Investigator Grants |
2018 |
Massachusetts |
STING Pathway Activation: The Missing Link between Genomic Instability and Antitumor Immunity in Osteosarcoma |
University of California San Francisco / Elizabeth Young, MD |
Young Investigator Grants |
2021 |
California |